Picomole Eyes Emerging Market Trials
Picomole Instruments Inc. of Moncton expects to close $1.2 million in equity funding this quarter with the intent of performing clinical studies on a breath-analysis device it believes will revolutionize diagnostics.
In an interview in his office overlooking downtown Moncton, CEO John Cormier said the company has a working, portable prototype of its breathalyzer-like device that can detect lung cancer by identifying markers in people’s breath.
The company plans to spend 2013 performing clinical studies on the device and examining foreign markets, most likely in Latin America or Asia, to